Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
Dumbing down HIV treatment hurts everybody

Bob Leahy says there is so much faulty information on what being on treatment means and when to start that it is hurting us all. But there are solutions which can successfully balance patient rights with the benefits of starting treatment early.

Published
11 February 2016
From
Positive Lite
Tenofovir resistance may develop in more than half of patients failing treatment in sub-Saharan Africa

More than half of people who experienced failure of a tenofovir-based antiretroviral regimen in sub-Saharan Africa had resistance to tenofovir, a meta-analysis of drug resistance studies published

Published
01 February 2016
By
Keith Alcorn
US: Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

What's New in the Guidelines? Revisions to the April 8, 2015, version of the guidelines are largely based on findings from two large, randomized controlled trials that addressed the optimal time to initiate antiretroviral therapy (ART)—START (Strategic Timing of Antiretroviral Therapy) and TEMPRANO.

Published
01 February 2016
From
AIDS.info
Young Men With Detectable Viral Loads More Likely to Engage in Risky Behavior

A new study on HIV-positive men and transgender women who have sex with men reported that participants with detectable viral loads were more likely to have anal sex without condoms than those who were virally suppressed, and that condom use was closely related to substance abuse. The study examined participants age 15 to 26 across the US from 2009 to 2012. Among those who had detectable viral loads, a full 44 percent reported condomless sex, a significant percentage higher than those who were virally suppressed but had condomless sex (which was only 25 percent).

Published
05 January 2016
From
HIVPlusMag
Cipla ready to launch low dose HIV drug efavirenz

Drug major Cipla Ltd today said it is ready to launch low dose 'Efavirenz' used in treatment of HIV infection.

Published
01 December 2015
From
Economic Times
Genvoya added to US recommended first-line options for HIV treatment

Based on efficacy and safety data from phase 3 randomized clinical trials, EVG/c/FTC/TAF will be added as one of the Recommended Initial Regimens for ART-naive adults and adolescents with estimated creatinine clearance ≥ 30 mL/min (AI).

Published
23 November 2015
From
AIDSinfo
How do we maximise global HIV treatment access? IAPAC Care Continuum Guidelines make recommendations

IAPAC, the International Association of Practitioners in AIDS Care, has issued a set of guidelines that aims to establish a common set of best practices to ensure

Published
09 November 2015
By
Gus Cairns
Many Countries Deny Antiretrovirals to Undocumented Migrants

Migrants who have come to Europe from low- and middle-income countries who become infected with HIV start antiretroviral therapy later than native populations, and when their CD4 counts are lower, new research indicates.

Published
28 October 2015
From
Medscape
START sub-studies show no differences in lung or neurocognitive function with early or later treatment

Participants who started antiretroviral therapy (ART) soon after HIV diagnosis in the large START trial showed no differences in lung function or neuropsychological performance when compared to people

Published
27 October 2015
By
Liz Highleyman
START sub-study shows more bone loss with earlier HIV treatment

Participants who started antiretroviral therapy (ART) soon after HIV diagnosis in the large START trial showed a greater decrease in bone density at the hip and spine

Published
27 October 2015
By
Liz Highleyman
← First12345...70Next →

Filter by country